These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1090 related items for PubMed ID: 22330997

  • 41. Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy.
    Goenka A, Magsanoc JM, Pei X, Schechter M, Kollmeier M, Cox B, Scardino PT, Eastham JA, Zelefsky MJ.
    Eur Urol; 2011 Dec; 60(6):1142-8. PubMed ID: 21855208
    [Abstract] [Full Text] [Related]

  • 42. Five-year follow-up using a prostate stent as fiducial in image-guided radiotherapy of prostate cancer.
    Carl J, Sander L.
    Acta Oncol; 2015 Jun; 54(6):862-7. PubMed ID: 25539443
    [Abstract] [Full Text] [Related]

  • 43. Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance.
    Sveistrup J, af Rosenschöld PM, Deasy JO, Oh JH, Pommer T, Petersen PM, Engelholm SA.
    Radiat Oncol; 2014 Feb 04; 9():44. PubMed ID: 24495815
    [Abstract] [Full Text] [Related]

  • 44. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment.
    Gauthier I, Carrier JF, Béliveau-Nadeau D, Fortin B, Taussky D.
    Int J Radiat Oncol Biol Phys; 2009 Jul 15; 74(4):1128-33. PubMed ID: 19147306
    [Abstract] [Full Text] [Related]

  • 45. A comparison of treatment outcome between fiducial-based and bone-based image guided radiotherapy in prostate cancer patients.
    Napieralska A, Majewski W, Kulik R, Głowacki G, Miszczyk L.
    Radiat Oncol; 2018 Nov 27; 13(1):235. PubMed ID: 30482212
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
    Vargas C, Martinez A, Kestin LL, Yan D, Grills I, Brabbins DS, Lockman DM, Liang J, Gustafson GS, Chen PY, Vicini FA, Wong JW.
    Int J Radiat Oncol Biol Phys; 2005 Aug 01; 62(5):1297-308. PubMed ID: 16029785
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
    Vargas C, Ghilezan M, Hollander M, Gustafson G, Korman H, Gonzalez J, Martinez A.
    J Urol; 2005 Sep 01; 174(3):882-7. PubMed ID: 16093980
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results.
    Lim TS, Cheung PC, Loblaw DA, Morton G, Sixel KE, Pang G, Basran P, Zhang L, Tirona R, Szumacher E, Danjoux C, Choo R, Thomas G.
    Int J Radiat Oncol Biol Phys; 2008 Sep 01; 72(1):85-92. PubMed ID: 18355982
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer.
    Wong WW, Schild SE, Vora SA, Halyard MY.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):24-9. PubMed ID: 15337536
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
    Søndergaard J, Høyer M, Petersen JB, Wright P, Grau C, Muren LP.
    Acta Oncol; 2009 Sep 01; 48(2):238-44. PubMed ID: 18759144
    [Abstract] [Full Text] [Related]

  • 60. Intensity-modulated radiotherapy (IMRT) to prostate and pelvic nodes-is pelvic lymph node coverage adequate with fiducial-based image-guided radiotherapy?
    Eminowicz G, Dean C, Shoffren O, Macdougall N, Wells P, Muirhead R.
    Br J Radiol; 2014 May 01; 87(1037):20130696. PubMed ID: 24646126
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 55.